Research.Patient.info
Homeostatic iron regulator gene-related hereditary hemochromatosis research hub
2 indexed studies · 1 currently recruiting
- authorisedTherapeutic exploratory (Phase II)
A Phase 2, Multicenter, Randomized, Placebo-controlled, Double-blind Study of the Efficacy and Safety of Vamifeport in Adult Subjects with HFE-related Hereditary Hemochromatosis (FERROCLEAR Study)
This study is testing a new medicine, Vamifeport, for adults with a condition called hereditary hemochromatosis. It aims to see if the medicine can reduce high iron levels in the liver and if it's safe to use.
Austria · Poland · Spain - recruitingPHASE2
Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HFE)-Related Hereditary Hemochromatosis
This study is testing a new medicine, Vamifeport, for people with a common type of iron overload called hereditary hemochromatosis. It aims to see if the medicine can reduce the amount of iron stored in the liver. Two groups will be compared: one getting the medicine and one getting a dummy pill.
United States · Australia · Austria